HEMOSTATIC ACTIVATION AND PROTEINURIA AS FACTORS IN THE PROGRESSION OF CHRONIC-RENAL-FAILURE

被引:17
作者
GORDGE, MP [1 ]
LEAKER, BR [1 ]
RYLANCE, PB [1 ]
NEILD, GH [1 ]
机构
[1] UCL, ST PHILIPS HOSP,COLL & MIDDLESEX SCH MED, INST UROL,DEPT RENAL MED,SHEFFIELD ST, LONDON WC2A 2EX, ENGLAND
关键词
CHRONIC RENAL FAILURE; GLOMERULOSCLEROSIS; HEMOSTASIS; PROTEINURIA;
D O I
10.1093/ndt/6.1.21
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Haemostatic activation was measured in patients with either non-diabetic chronic renal failure (CRF) or diabetic nephropathy. We have investigated the relationship between these haemostatic markers and the rate of progression of renal failure. When compared with age- and sex-matched healthy controls, both patient groups showed significantly elevated plasma concentrations of D dimer, von Willebrand factor antigen (vWFAg), and C-reactive protein (CRP) (all P < 0.001), as well as an increase in spontaneous platelet aggregation (P < 0.01). Plasma concentration of platelet factor 4 was slightly but not significantly increased. Serum thromboxane was subnormal (P < 0.01). Multiple regression analysis showed that in non-diabetic CRF proteinuria and serum TxB2 were independently related to the rate of progression of renal failure; in diabetic nephropathy proteinuria and vWFAg were independently related to the rate of progression. In both groups the relationship was stronger with proteinuria (standardised regression coefficients 0.56 and 0.45 respectively) than with serum TxB2 (0.29) or with vWFAg (0.37). We have found haemostatic activation in both non-diabetic and diabetic progressive renal failure. Proteinuria, and also in this study serum TxB2 and vWFAg, appear to be determining factors in the progression of renal failure, and their measurement may have prognostic value.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 23 条
[1]   RELEASE, DISTRIBUTION, AND CLEARANCE OF HUMAN BETA-THROMBOGLOBULIN AND PLATELET FACTOR-4 [J].
DAWES, J ;
SMITH, RC ;
PEPPER, DS .
THROMBOSIS RESEARCH, 1978, 12 (05) :851-861
[2]   FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS - ANALOGIES TO ATHEROSCLEROSIS [J].
DIAMOND, JR ;
KARNOVSKY, MJ .
KIDNEY INTERNATIONAL, 1988, 33 (05) :917-924
[3]  
GEORGE CRP, 1974, NEW ENGL J MED, V293, P1111
[4]  
GORDGE MP, 1989, THROMB HAEMOSTASIS, V61, P522
[5]  
GORDGE MP, 1988, THROMB HAEMOSTASIS, V60, P83
[6]   INFLUENCE OF RANGE OF RENAL-FUNCTION AND LIVER-DISEASE ON PREDICTABILITY OF CREATININE CLEARANCE [J].
HULL, JH ;
HAK, LJ ;
KOCH, GG ;
WARGIN, WA ;
CHI, SL ;
MATTOCKS, AM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (04) :516-521
[7]  
KLAHR S, 1986, CONTEMP ISS NEPHROL, V14, P45
[8]  
LANE DA, 1984, THROMB HAEMOSTASIS, V52, P183
[9]   THE SIGNIFICANCE OF FIBRINOGEN DERIVATIVES IN PLASMA IN HUMAN RENAL-FAILURE [J].
LANE, DA ;
IRELAND, H ;
KNIGHT, I ;
WOLFF, S ;
KYLE, P ;
CURTIS, JR .
BRITISH JOURNAL OF HAEMATOLOGY, 1984, 56 (02) :251-260
[10]  
MILANI L, 1983, CLIN NEPHROL, V20, P235